• Mashup Score: 3

    This cross-sectional study investigates whether differences in radiotherapy technologies, treatment length, and spending exist between traditional Medicare and Medicare Advantage beneficiaries with cancer.

    Tweet Tweets with this article
    • #medicareAdvantage pts with cancer undergoing #radiotherapy had HIGHER estimated spending & greater mean treatment length. Despite lower utilization of more expensive advanced treatment modalities, MA was NOT associated with cost savings. @JAMANetworkOpen https://t.co/upZ2F3eGxk